ArticleFrontiers in cardiovascular medicine2025
From novice to expert: the reproducibility of 3D echocardiographic right ventricular assessment in heart failure patients.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Right ventricular (RV) function is a key prognostic factor in patients with heart failure with mildly reduced (HFmrEF) or reduced ejection fraction (HFrEF). While two-dimensional echocardiography (2DE) is used due to its availability, three-dimensional echocardiography (3DE) provides more reproducible measurements, though its use is limited by training requirements. Objective: To assess whether cardiologists experienced in 2DE with limited 3DE exposure can obtain feasible and reproducible 3DE measurements of RV size and function after a short training in patients with HFmrEF/HFrEF. Methods: 161 patients hospitalized for decompensated HFmrEF/HFrEF (mean age 58 ± 17 years, 71% males, 3D LVEF 35 ± 10%) were analyzed in the study using 2DE and 3DE assessments. Measurements were performed by an Expert in 2DE and 3DE, and by a Beginner with experience in 2DE but only three months of practical training in 3DE. Measurements were taken at baseline (T0) and after three months of practical training in 3DE (T1) to assess intra- and inter-observer reproducibility. Results: The study demonstrated high intra-observer reproducibility for 2DE parameters by the Beginner with 95% ICCs of: 0.98 (0.98-0.99) for RV diameter, 0.97 (0.94-0.98) for TAPSE, 0.92 (0.90-0.99) for RVFAC, 0.96 (0.95-0.98) for S', and 0.98 (0.97-0.99) for RVFWS. Conversely, there was a slightly lower inter-observer reproducibility compared to the Expert for the same 2D parameters, with ICCs of: 0.81 (0.71-0.87) for RV diameter, 0.91 (0.88-0.94) for TAPSE, 0.86 (0.81-0.90) for RVFAC, 0.90 (0.88-0.93) for S', and 0.93 (0.85-0.96) for RVFWS, respectively. The Beginner's intra-observer reproducibility for 3DE parameters was good at baseline, after short theoretical training in 3DE, with ICCs of: 0.87 (0.83-0.91) for RVEDV, 0.85 (0.79-0.89) for RVESV, and 0.90 (0.87-0.93) for RVEF, respectively, and improved significantly after 3 months of practice in 3DE, with ICCs of: 0.96 (0.92-0.97) for RVEDV, 0.95 (0.94-0.98) for RVESV, and 0.95 (0.91-0.97) for RVEF. Bland-Altman analysis showed no systematic bias between the Expert and Beginner for both 2DE and 3DE measurements, confirming the robustness of 3DE across different experience levels. Conclusions: After brief training, 2DE-proficient cardiologists can perform accurate and reproducible 3DE measurements of RV function, supporting broader clinical use of 3DE in heart failure assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.